Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000307107 | SCV000341688 | uncertain significance | not provided | 2016-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001204777 | SCV001375998 | uncertain significance | Qualitative or quantitative defects of dysferlin | 2022-06-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 853 of the DYSF protein (p.Arg853Trp). This variant is present in population databases (rs749542779, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. ClinVar contains an entry for this variant (Variation ID: 287785). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000307107 | SCV001783174 | uncertain significance | not provided | 2019-09-27 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002518991 | SCV003576449 | uncertain significance | Inborn genetic diseases | 2021-09-17 | criteria provided, single submitter | clinical testing | The c.2557C>T (p.R853W) alteration is located in exon 25 (coding exon 25) of the DYSF gene. This alteration results from a C to T substitution at nucleotide position 2557, causing the arginine (R) at amino acid position 853 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001828244 | SCV002079864 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-05-15 | no assertion criteria provided | clinical testing |